{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:20:52Z","timestamp":1794576052818,"version":"4.9.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T00:00:00Z","timestamp":1772668800000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82370669, 82201964"],"award-info":[{"award-number":["82370669, 82201964"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-026-03119-x","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T14:35:22Z","timestamp":1772462122000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Association of the C-reactive protein\u2013triglyceride\u2013glucose index with metabolic dysfunction-associated steatotic liver disease and long-term all-cause and cardiovascular mortality: evidence from two nationwide prospective cohort studies"],"prefix":"10.1186","volume":"25","author":[{"given":"Xue-Feng","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-Jie","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Fa","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bao-Jie","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-Yu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Sui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Quan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Bo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Hui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Ping","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang-Xu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Zhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Rui","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jiao","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Tian","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hai","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,2]]},"reference":[{"key":"3119_CR1","doi-asserted-by":"crossref","unstructured":"Tilg H, Petta S, Stefan N, Targher G. Metabolic dysfunction-associated steatotic liver disease in adults: a review. JAMA. 2025.","DOI":"10.1001\/jama.2025.26737"},{"key":"3119_CR2","doi-asserted-by":"publisher","first-page":"1673662","DOI":"10.3389\/fnut.2025.1673662","volume":"12","author":"ZQ Liu","year":"2025","unstructured":"Liu ZQ, Zhou BG, Fang JW, Yu Y, Jiang X, Chen XY, Wang WJ, Fu XY, Xia JL, Liu BJ, et al. Protective role of the planetary health diet index against metabolic dysfunction-associated steatotic liver disease: global and individual evidence. Front Nutr. 2025;12:1673662.","journal-title":"Front Nutr"},{"key":"3119_CR3","doi-asserted-by":"crossref","unstructured":"Mustafa A, Kite C, Lagojda L, Dallaway A, Chatha KK, Than NN, Kassi E, Kyrou I, Randeva HS. Cardiovascular disease in the context of metabolic dysfunction-associated steatotic liver disease (MASLD): a comprehensive narrative review. Int J Mol Sci. 2025;26(23).","DOI":"10.3390\/ijms262311275"},{"issue":"12","key":"3119_CR4","doi-asserted-by":"publisher","first-page":"101602","DOI":"10.1016\/j.jhepr.2025.101602","volume":"7","author":"H Zheng","year":"2025","unstructured":"Zheng H, Wu K, Zheng H, Chen G, Lan Y, Chen S, Casu G, Sechi LA, Wu S, Vidili G, et al. High systemic inflammation response index and increased cardiovascular risk and mortality in MASLD: a prospective cohort study. JHEP Rep. 2025;7(12):101602.","journal-title":"JHEP Rep"},{"key":"3119_CR5","doi-asserted-by":"crossref","unstructured":"Shao X, Tan Z, Sun L, Fu Y, Chen A, Chen J, Bai G, Zhang J. Association between triglyceride-glucose index combined with a body shape index and atherosclerotic cardiovascular disease risk varies by glycemic status: insights from the UK Biobank. Cardiovasc Diabetol 2025.","DOI":"10.1186\/s12933-025-03021-y"},{"issue":"1","key":"3119_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1186\/s12933-025-02960-w","volume":"24","author":"L Zhang","year":"2025","unstructured":"Zhang L, Li S, Liu D, Gui J, Hu J, Wang Q, Mao W. The relationship between C-reactive protein-triglyceride-glucose index and cardiovascular disease: insights from the China health and retirement longitudinal study (CHARLS). Cardiovasc Diabetol. 2025;24(1):410.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR7","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-025-02848-9","volume":"24","author":"H Ou","year":"2025","unstructured":"Ou H, Wei M, Li X, Xia X. C-reactive protein-triglyceride glucose index in evaluating cardiovascular disease and all-cause mortality incidence among individuals across stages 0\u20133 of cardiovascular-kidney-metabolic syndrome: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):296.","journal-title":"Cardiovasc Diabetol"},{"key":"3119_CR8","doi-asserted-by":"publisher","first-page":"1607456","DOI":"10.3389\/fimmu.2025.1607456","volume":"16","author":"H Li","year":"2025","unstructured":"Li H, Ge J, Tong W, Chen P, Sun P, Lu S, Sun L, Chen Y, Li Y, Wang J, et al. The association of exogenous dietary antioxidant micronutrient intake and consumption timing with urinary albumin excretion among U.S. adults. Front Immunol. 2025;16:1607456.","journal-title":"Front Immunol"},{"key":"3119_CR9","doi-asserted-by":"crossref","unstructured":"Kim D, Danpanichkul P, Wijarnpreecha K, Loomba R, Ahmed A. Social determinants of health in metabolic dysfunction-associated steatotic liver disease and all-cause\/cause-specific mortality. Aliment Pharmacol Ther. 2025.","DOI":"10.1111\/apt.70409"},{"key":"3119_CR10","doi-asserted-by":"publisher","first-page":"1530174","DOI":"10.3389\/fimmu.2025.1530174","volume":"16","author":"X Jin","year":"2025","unstructured":"Jin X, Tong W, Sun L, Lu S, Sun P, Li H, Liu Y. Association of composite dietary antioxidant index with high risk of prostate cancer in middle-aged and elderly men: insights from NHANES. Front Immunol. 2025;16:1530174.","journal-title":"Front Immunol"},{"issue":"1","key":"3119_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s12933-025-02754-0","volume":"24","author":"L Lu","year":"2025","unstructured":"Lu L, Chen Y, Liu B, Li X, Wang J, Nie Z, Fu X. Association between cumulative changes of the triglyceride glucose index and incidence of stroke in a population with cardiovascular-kidney-metabolic syndrome stage 0\u20133: a nationwide prospective cohort study. Cardiovasc Diabetol. 2025;24(1):202.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR12","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1186\/s12933-025-02980-6","volume":"24","author":"K Qu","year":"2025","unstructured":"Qu K, Dal Canto E, van Ommen ALN, Kamar SA, Teske AJ, Cramer MJ, Verhaar MC, Duncker DJ, Rutten FH, Kardys I, et al. Proteome organ aging and cardiometabolic risk in a population at risk for heart failure. Cardiovasc Diabetol. 2025;24(1):430.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1186\/s12933-025-02616-9","volume":"24","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wu J, Li T, Qu Y, Wang Y. Association of triglyceride-glucose related indices with mortality among individuals with MASLD combined with prediabetes or diabetes. Cardiovasc Diabetol. 2025;24(1):52.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12933-024-02572-w","volume":"24","author":"Y Qiao","year":"2025","unstructured":"Qiao Y, Wang Y, Chen C, Huang Y, Zhao C. Association between triglyceride-glucose (TyG) related indices and cardiovascular diseases and mortality among individuals with metabolic dysfunction-associated steatotic liver disease: a cohort study of UK Biobank. Cardiovasc Diabetol. 2025;24(1):12.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13098-024-01571-x","volume":"17","author":"M Hu","year":"2025","unstructured":"Hu M, Yang J, Gao B, Wu Z, Wu Y, Hu D, Shen Q, Chen L. Prediction of MASLD using different screening indexes in Chinese type 2 diabetes mellitus. Diabetol Metab Syndr. 2025;17(1):10.","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"3119_CR16","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/s12933-024-02343-7","volume":"23","author":"Q Chen","year":"2024","unstructured":"Chen Q, Hu P, Hou X, Sun Y, Jiao M, Peng L, Dai Z, Yin X, Liu R, Li Y, et al. Association between triglyceride-glucose related indices and mortality among individuals with non-alcoholic fatty liver disease or metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):232.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR17","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s12944-025-02736-x","volume":"24","author":"L Xiang","year":"2025","unstructured":"Xiang L, Li X, Gong J, He L, Li W, Chen J, Feng R, Du S, Ye W. The nomenclature of fatty liver disease and its impact on obesity traits, insulin resistance, and hepatic fibrosis. Lipids Health Dis. 2025;24(1):339.","journal-title":"Lipids Health Dis"},{"issue":"1","key":"3119_CR18","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-024-02287-y","volume":"23","author":"Y Min","year":"2024","unstructured":"Min Y, Wei X, Wei Z, Song G, Zhao X, Lei Y. Prognostic effect of triglyceride glucose-related parameters on all-cause and cardiovascular mortality in the United States adults with metabolic dysfunction-associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):188.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"3119_CR19","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12933-025-02941-z","volume":"24","author":"M Gan","year":"2025","unstructured":"Gan M, Chen B, Qin M, Zhang L, Wang X. Association between atherogenic index of plasma (AIP) and all-cause and cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease (MASLD): a cohort study based on NHANES 1999\u20132018. Cardiovasc Diabetol. 2025;24(1):391.","journal-title":"Cardiovasc Diabetol"},{"key":"3119_CR20","doi-asserted-by":"crossref","unstructured":"Ibarra-Reynoso LDR, Rodriguez-Hernandez N, Lazo-de-la-Vega-Monroy ML, Garcia-Ramirez JR, Ruiz-Noa Y, Jordan-Perez B, Garnelo-Caba\u00f1as S, Mu\u00f1oz-Cornejo V, Preciado-Puga MDC. Adiposity and metabolic indices in the diagnosis and histological stage association of metabolic dysfunction-associated steatotic liver disease. J Clin Med. 2025;14(23).","DOI":"10.3390\/jcm14238365"},{"issue":"2","key":"3119_CR21","doi-asserted-by":"publisher","first-page":"e70087","DOI":"10.1002\/mco2.70087","volume":"6","author":"H Zeng","year":"2025","unstructured":"Zeng H, Fang L, Yang Z, Zhao X, Chen H, Xing P, Niu Z, Li Z, Li Z, Zhao J, et al. Prognostic and predictive effects of new steatotic liver disease nomenclatures: a large population-based study. MedComm (2020). 2025;6(2):e70087.","journal-title":"MedComm (2020)"},{"issue":"1","key":"3119_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1186\/s12933-024-02334-8","volume":"23","author":"M Duan","year":"2024","unstructured":"Duan M, Zhao X, Li S, Miao G, Bai L, Zhang Q, Yang W, Zhao X. Metabolic score for insulin resistance (METS-IR) predicts all-cause and cardiovascular mortality in the general population: evidence from NHANES 2001\u20132018. Cardiovasc Diabetol. 2024;23(1):243.","journal-title":"Cardiovasc Diabetol"},{"key":"3119_CR23","doi-asserted-by":"publisher","first-page":"1569798","DOI":"10.3389\/fnut.2025.1569798","volume":"12","author":"C Zhao","year":"2025","unstructured":"Zhao C, Zhao L, Liu Y, Sun LQ, Li XR, Wang Y, Sun W. The impact of serum uric acid on biological aging and mortality risk: insights from the NHANES and CHARLS cohorts. Front Nutr. 2025;12:1569798.","journal-title":"Front Nutr"},{"key":"3119_CR24","doi-asserted-by":"publisher","first-page":"155954","DOI":"10.1016\/j.metabol.2024.155954","volume":"157","author":"XL Lin","year":"2024","unstructured":"Lin XL, Zhang QW, Chen GF, Yang SJ, Li XB, Deng WY. Global, regional, and national trends in metabolic risk factor-associated mortality among the working-age population from 1990\u20132019: an age-period-cohort analysis of the Global Burden of Disease 2019 study. Metabolism. 2024;157:155954.","journal-title":"Metabolism"},{"issue":"1","key":"3119_CR25","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1186\/s12933-024-02371-3","volume":"23","author":"R Minutolo","year":"2024","unstructured":"Minutolo R, Simeon V, De Nicola L, Chiodini P, Galiero R, Rinaldi L, Caturano A, Vetrano E, Sardu C, Marfella R, et al. Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial. Cardiovasc Diabetol. 2024;23(1):285.","journal-title":"Cardiovasc Diabetol"},{"issue":"3","key":"3119_CR26","doi-asserted-by":"publisher","first-page":"107496","DOI":"10.1016\/j.jdiacomp.2019.107496","volume":"34","author":"O Mansour","year":"2020","unstructured":"Mansour O, Golden SH, Yeh HC. Disparities in mortality among adults with and without diabetes by sex and race. J Diabetes Complicat. 2020;34(3):107496.","journal-title":"J Diabetes Complicat"},{"issue":"12","key":"3119_CR27","doi-asserted-by":"publisher","first-page":"e2449855","DOI":"10.1001\/jamanetworkopen.2024.49855","volume":"7","author":"C Li","year":"2024","unstructured":"Li C, Howard SP, Rogers CR, Andrzejak S, Gilbert KL, Watts KJ, Bevel MS, Moody MD, Langston ME, Doty JV, et al. Allostatic load, educational attainment, and risk of cancer mortality among US men. JAMA Netw Open. 2024;7(12):e2449855.","journal-title":"JAMA Netw Open"},{"issue":"10226","key":"3119_CR28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/S0140-6736(19)32008-2","volume":"395","author":"S Yusuf","year":"2020","unstructured":"Yusuf S, Joseph P, Rangarajan S, Islam S, Mente A, Hystad P, Brauer M, Kutty VR, Gupta R, Wielgosz A, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795\u2013808.","journal-title":"Lancet"},{"issue":"1","key":"3119_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2188\/jea.JE20170112","volume":"29","author":"L Zha","year":"2019","unstructured":"Zha L, Sobue T, Kitamura T, Kitamura Y, Sawada N, Iwasaki M, Sasazuki S, Yamaji T, Shimazu T, Tsugane S. Changes in smoking status and mortality from all causes and lung cancer: a longitudinal analysis of a population-based study in Japan. J Epidemiol. 2019;29(1):11\u20137.","journal-title":"J Epidemiol"},{"key":"3119_CR30","doi-asserted-by":"publisher","first-page":"d671","DOI":"10.1136\/bmj.d671","volume":"342","author":"PE Ronksley","year":"2011","unstructured":"Ronksley PE, Brien SE, Turner BJ, Mukamal KJ, Ghali WA. Association of alcohol consumption with selected cardiovascular disease outcomes: a systematic review and meta-analysis. BMJ. 2011;342:d671.","journal-title":"BMJ"},{"issue":"10051","key":"3119_CR31","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1016\/S0140-6736(16)30370-1","volume":"388","author":"U Ekelund","year":"2016","unstructured":"Ekelund U, Steene-Johannessen J, Brown WJ, Fagerland MW, Owen N, Powell KE, Bauman A, Lee IM. Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women. Lancet. 2016;388(10051):1302\u201310.","journal-title":"Lancet"},{"issue":"525","key":"3119_CR32","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/01621459.2017.1401540","volume":"114","author":"A Bellach","year":"2019","unstructured":"Bellach A, Kosorok MR, R\u00fcschendorf L, Fine JP. Weighted NPMLE for the subdistribution of a competing risk. J Am Stat Assoc. 2019;114(525):259\u201370.","journal-title":"J Am Stat Assoc"},{"issue":"11","key":"3119_CR33","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1111\/apt.70128","volume":"61","author":"D Kim","year":"2025","unstructured":"Kim D, Danpanichkul P, Wijarnpreecha K, Cholankeril G, Ahmed A. Association of high-sensitivity troponins in metabolic dysfunction-associated steatotic liver disease with all-cause and cause-specific mortality. Aliment Pharmacol Ther. 2025;61(11):1785\u201393.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"3119_CR34","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s12933-024-02263-6","volume":"23","author":"A Colantoni","year":"2024","unstructured":"Colantoni A, Bucci T, Cocomello N, Angelico F, Ettorre E, Pastori D, Lip GYH, Del Ben M, Baratta F. Lipid-based insulin-resistance markers predict cardiovascular events in metabolic dysfunction associated steatotic liver disease. Cardiovasc Diabetol. 2024;23(1):175.","journal-title":"Cardiovasc Diabetol"},{"issue":"9459","key":"3119_CR35","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0140-6736(05)70804-7","volume":"365","author":"A Sj\u00f6holm","year":"2005","unstructured":"Sj\u00f6holm A, Nystr\u00f6m T. Endothelial inflammation in insulin resistance. Lancet. 2005;365(9459):610\u20132.","journal-title":"Lancet"},{"key":"3119_CR36","doi-asserted-by":"crossref","unstructured":"Ya J, Bayraktutan U. Vascular ageing: mechanisms, risk factors, and treatment strategies. Int J Mol Sci 2023, 24(14).","DOI":"10.3390\/ijms241411538"},{"key":"3119_CR37","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.jare.2024.06.016","volume":"71","author":"Y Xing","year":"2025","unstructured":"Xing Y, Lin X. Challenges and advances in the management of inflammation in atherosclerosis. J Adv Res. 2025;71:317\u201335.","journal-title":"J Adv Res"},{"issue":"1","key":"3119_CR38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s11154-016-9341-8","volume":"17","author":"A Ceriello","year":"2016","unstructured":"Ceriello A, Genovese S. Atherogenicity of postprandial hyperglycemia and lipotoxicity. Rev Endocr Metab Disord. 2016;17(1):111\u20136.","journal-title":"Rev Endocr Metab Disord"},{"issue":"7","key":"3119_CR39","doi-asserted-by":"publisher","first-page":"159330","DOI":"10.1016\/j.bbalip.2023.159330","volume":"1868","author":"R Fan","year":"2023","unstructured":"Fan R, An X, Wang Y, Zhang J, Liu S, Bai J, Li J, Lin Q, Xie Y, Xia Y, et al. Severe hypertriglyceridemia caused by Gpihbp1 deficiency facilitates vascular remodeling through increasing endothelial activation and oxidative stress. Biochim Biophys Acta Mol Cell Biol Lipids. 2023;1868(7):159330.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"11","key":"3119_CR40","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nrcardio.2013.140","volume":"10","author":"GF Watts","year":"2013","unstructured":"Watts GF, Ooi EM, Chan DC. Demystifying the management of hypertriglyceridaemia. Nat Rev Cardiol. 2013;10(11):648\u201361.","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"3119_CR41","doi-asserted-by":"publisher","first-page":"e667","DOI":"10.1210\/clinem\/dgae276","volume":"110","author":"D Tric\u00f2","year":"2025","unstructured":"Tric\u00f2 D, Rebelos E, Astiarraga B, Baldi S, Scozzaro T, Sacchetta L, Chiriac\u00f2 M, Mari A, Ferrannini E, Muscelli E, et al. Effects of Hypertriglyceridemia With or Without NEFA Elevation on \u03b2-cell Function and Insulin Clearance and Sensitivity. J Clin Endocrinol Metab. 2025;110(3):e667\u201374.","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"3119_CR42","doi-asserted-by":"publisher","first-page":"H1044","DOI":"10.1152\/ajpheart.00516.2008","volume":"295","author":"F Bourgoin","year":"2008","unstructured":"Bourgoin F, Bachelard H, Badeau M, M\u00e9lan\u00e7on S, Pitre M, Larivi\u00e8re R, Nadeau A. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiol Heart Circ Physiol. 2008;295(3):H1044\u201355.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"9","key":"3119_CR43","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","volume":"107","author":"F Giacco","year":"2010","unstructured":"Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058\u201370.","journal-title":"Circ Res"},{"issue":"1","key":"3119_CR44","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s11010-022-04496-z","volume":"478","author":"SK Raut","year":"2023","unstructured":"Raut SK, Khullar M. Oxidative stress in metabolic diseases: current scenario and therapeutic relevance. Mol Cell Biochem. 2023;478(1):185\u201396.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"3119_CR45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s10020-024-00824-9","volume":"30","author":"T Yang","year":"2024","unstructured":"Yang T, Qi F, Guo F, Shao M, Song Y, Ren G, Linlin Z, Qin G, Zhao Y. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med. 2024;30(1):71.","journal-title":"Mol Med"},{"key":"3119_CR46","doi-asserted-by":"crossref","unstructured":"Uribarri J, Tuttle KR. Dietary advanced glycation end products and cardiovascular-kidney-metabolic complications. Clin J Am Soc Nephrol. 2025.","DOI":"10.2215\/CJN.0000000859"},{"issue":"12","key":"3119_CR47","doi-asserted-by":"publisher","first-page":"2867","DOI":"10.2337\/diabetes.52.12.2867","volume":"52","author":"JR Singleton","year":"2003","unstructured":"Singleton JR, Smith AG, Russell JW, Feldman EL. Microvascular complications of impaired glucose tolerance. Diabetes. 2003;52(12):2867\u201373.","journal-title":"Diabetes"},{"issue":"7785","key":"3119_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","volume":"576","author":"M Roden","year":"2019","unstructured":"Roden M, Shulman GI. The integrative biology of type 2 diabetes. Nature. 2019;576(7785):51\u201360.","journal-title":"Nature"},{"issue":"6","key":"3119_CR49","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1016\/j.apsb.2023.01.012","volume":"13","author":"X Jin","year":"2023","unstructured":"Jin X, Qiu T, Li L, Yu R, Chen X, Li C, Proud CG, Jiang T. Pathophysiology of obesity and its associated diseases. Acta Pharm Sin B. 2023;13(6):2403\u201324.","journal-title":"Acta Pharm Sin B"},{"issue":"12","key":"3119_CR50","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1042\/CS20150431","volume":"129","author":"JB McPhee","year":"2015","unstructured":"McPhee JB, Schertzer JD. Immunometabolism of obesity and diabetes: microbiota link compartmentalized immunity in the gut to metabolic tissue inflammation. Clin Sci (Lond). 2015;129(12):1083\u201396.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"3119_CR51","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12933-019-0870-9","volume":"18","author":"SN Randeria","year":"2019","unstructured":"Randeria SN, Thomson GJA, Nell TA, Roberts T, Pretorius E. Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovasc Diabetol. 2019;18(1):72.","journal-title":"Cardiovasc Diabetol"},{"key":"3119_CR52","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119352"},{"issue":"1","key":"3119_CR53","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1042\/BST20200611","volume":"49","author":"AM Clyne","year":"2021","unstructured":"Clyne AM. Endothelial response to glucose: dysfunction, metabolism, and transport. Biochem Soc Trans. 2021;49(1):313\u201325.","journal-title":"Biochem Soc Trans"},{"issue":"9","key":"3119_CR54","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-023-05964-x","volume":"66","author":"V Lyssenko","year":"2023","unstructured":"Lyssenko V, Vaag A. Genetics of diabetes-associated microvascular complications. Diabetologia. 2023;66(9):1601\u201313.","journal-title":"Diabetologia"},{"issue":"1","key":"3119_CR55","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s12933-025-02819-0","volume":"24","author":"Z Tian","year":"2025","unstructured":"Tian Z, Yang L, Li Y, Huang Y, Yang J, Xue F. Associations of different insulin resistance-related indices with the incidence and progression trajectory of cardiometabolic multimorbidity: a prospective cohort study from UK biobank. Cardiovasc Diabetol. 2025;24(1):257.","journal-title":"Cardiovasc Diabetol"},{"issue":"10","key":"3119_CR56","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1016\/j.celrep.2018.05.010","volume":"23","author":"CA Reardon","year":"2018","unstructured":"Reardon CA, Lingaraju A, Schoenfelt KQ, Zhou G, Cui C, Jacobs-El H, Babenko I, Hoofnagle A, Czyz D, Shuman H, et al. Obesity and insulin resistance promote atherosclerosis through an IFN\u03b3-regulated macrophage protein network. Cell Rep. 2018;23(10):3021\u201330.","journal-title":"Cell Rep"},{"issue":"7","key":"3119_CR57","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/s41569-023-00847-5","volume":"20","author":"PL Valenzuela","year":"2023","unstructured":"Valenzuela PL, Carrera-Bastos P, Castillo-Garc\u00eda A, Lieberman DE, Santos-Lozano A, Lucia A. Obesity and the risk of cardiometabolic diseases. Nat Rev Cardiol. 2023;20(7):475\u201394.","journal-title":"Nat Rev Cardiol"},{"issue":"9","key":"3119_CR58","first-page":"1777","volume":"41","author":"B Bansal","year":"2025","unstructured":"Bansal B, Lajeunesse-Trempe F, Keshvani N, Lavie CJ, Pandey A. Impact of metabolic dysfunction-associated steatotic liver disease on cardiovascular structure, function, and the risk of heart failure. Can J Cardiol. 2025;41(9):1777\u201393.","journal-title":"Can J Cardiol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-026-03119-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-026-03119-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T09:04:33Z","timestamp":1772701473000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12933-026-03119-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,2]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3119"],"URL":"https:\/\/doi.org\/10.1186\/s12933-026-03119-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,2]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The National Centre for Health Statistics (NCHS) and the Centres for Disease Control and Prevention (CDC) are responsible for conducting NHANES. Additionally, the NCHS Research Ethics Review Committee examined and approved the NHANES study protocol. Written informed consent was given by each NHANES participant. All participants gave written informed consent, and CHARLS was authorised by Peking University\u2019s Institutional Review Board (approval number: IRB00001052-11015 for the home survey and IRB00001052-11014 for blood samples).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}